Panpan Liu

3.9k total citations
142 papers, 2.8k citations indexed

About

Panpan Liu is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Panpan Liu has authored 142 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pathology and Forensic Medicine, 45 papers in Oncology and 30 papers in Molecular Biology. Recurrent topics in Panpan Liu's work include Lymphoma Diagnosis and Treatment (41 papers), Viral-associated cancers and disorders (20 papers) and Tea Polyphenols and Effects (16 papers). Panpan Liu is often cited by papers focused on Lymphoma Diagnosis and Treatment (41 papers), Viral-associated cancers and disorders (20 papers) and Tea Polyphenols and Effects (16 papers). Panpan Liu collaborates with scholars based in China, United States and Germany. Panpan Liu's co-authors include Shijun Wen, Peng Huang, Yi Xia, Guoxin Hou, Yumin Hu, Zhiming Li, Peng Sun, Jing Yang, Yu Wang and Mengqi Yang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Panpan Liu

129 papers receiving 2.7k citations

Peers

Panpan Liu
Soo Jung Lee South Korea
Matthias Rath Germany
Qiuhua Li China
Wei‐Hwa Lee Taiwan
Shin Kim South Korea
Karol Kajo Slovakia
Weijia Zhang China
Hui Luo China
Alexandru Irimie Romania
Soo Jung Lee South Korea
Panpan Liu
Citations per year, relative to Panpan Liu Panpan Liu (= 1×) peers Soo Jung Lee

Countries citing papers authored by Panpan Liu

Since Specialization
Citations

This map shows the geographic impact of Panpan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panpan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panpan Liu more than expected).

Fields of papers citing papers by Panpan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panpan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panpan Liu. The network helps show where Panpan Liu may publish in the future.

Co-authorship network of co-authors of Panpan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Panpan Liu. A scholar is included among the top collaborators of Panpan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panpan Liu. Panpan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Zhang, Yuchen, Ning Su, Zhihua Li, et al.. (2024). Toripalimab plus anlotinib in patients with recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm phase 2 trial (TORAL). Cell Reports Medicine. 5(12). 101833–101833. 4 indexed citations
5.
Li, Jiangjiang, Jingyu Tian, Panpan Liu, et al.. (2024). Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature Communications. 15(1). 3445–3445. 16 indexed citations
6.
Liu, Panpan, et al.. (2023). LncRNA H19 Contributes to Smoke-Related Chronic Obstructive Pulmonary Disease by Targeting miR-181/PDCD4 Axis. COPD Journal of Chronic Obstructive Pulmonary Disease. 20(1). 119–125. 2 indexed citations
7.
Su, Ning, Yi Cao, Yi Xia, et al.. (2023). Anlotinib as a third-line or further treatment for recurrent or metastatic nasopharyngeal carcinoma: a single-arm, phase 2 clinical trial. BMC Medicine. 21(1). 423–423. 8 indexed citations
8.
9.
Lin, Feng, Shiwei Gao, Panpan Liu, et al.. (2023). Microbial Diversity and Characteristic Quality Formation of Qingzhuan Tea as Revealed by Metagenomic and Metabolomic Analysis during Pile Fermentation. Foods. 12(19). 3537–3537. 3 indexed citations
10.
Gao, Shiwei, Pengcheng Zheng, Zhihui Feng, et al.. (2023). Dynamic Changes in Non-Volatile Components during Steamed Green Tea Manufacturing Based on Widely Targeted Metabolomic Analysis. Foods. 12(7). 1551–1551. 16 indexed citations
11.
Liu, Panpan, Meilan Zhang, Hongchang Gao, et al.. (2023). Regulation of whole-transcriptome sequencing expression in COPD after personalized precise exercise training: a pilot study. Respiratory Research. 24(1). 156–156. 5 indexed citations
12.
Han, Xue, Panpan Liu, Bin Zheng, et al.. (2022). 6-Gingerol exerts a protective effect against hypoxic injury through the p38/Nrf2/HO-1 and p38/NF-κB pathway in H9c2 cells. The Journal of Nutritional Biochemistry. 104. 108975–108975. 14 indexed citations
13.
Gao, Hongchang, Meilan Zhang, Jinrui Wang, et al.. (2021). Atractylon Treatment Attenuates Pulmonary Fibrosis via Regulation of the mmu_circ_0000981/miR-211-5p/TGFBR2 Axis in an Ovalbumin-Induced Asthma Mouse Model. Inflammation. 44(5). 1856–1864. 18 indexed citations
14.
Cai, Jun, Xiao‐Peng Tian, Shu‐Yun Ma, et al.. (2021). A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study. British Journal of Cancer. 125(3). 402–412. 11 indexed citations
15.
Li, Da, Jiancong Weng, Panpan Liu, et al.. (2021). Neurological outcomes of untreated brainstem cavernous malformations in a prospective observational cohort and literature review. Stroke and Vascular Neurology. 6(4). 501–510. 7 indexed citations
16.
Nie, Man, Linbin Yang, Xiwen Bi, et al.. (2018). Neutrophil Extracellular Traps Induced by IL8 Promote Diffuse Large B-cell Lymphoma Progression via the TLR9 Signaling. Clinical Cancer Research. 25(6). 1867–1879. 206 indexed citations
17.
Liu, Panpan, Kefeng Wang, Jietian Jin, et al.. (2018). Role of radiation therapy in primary breast diffuse large B‐cell lymphoma in the Rituximab era: a SEER database analysis. Cancer Medicine. 7(5). 1845–1851. 12 indexed citations
18.
Yu, Juanjuan, Yongxue Zhang, Jun‐Ming Liu, et al.. (2018). Proteomic discovery of H2O2 response in roots and functional characterization of PutGLP gene from alkaligrass. Planta. 248(5). 1079–1099. 22 indexed citations
19.
Liu, Panpan, et al.. (2016). Damage to Basic Needs of Being Excluded Alone and Excluded with Others. 24(6). 970. 2 indexed citations
20.
Liu, Panpan, Yi Xia, Xi-Wen Bi, et al.. (2016). Racial patterns of patients with primary mediastinal large B-cell lymphoma. Medicine. 95(27). e4054–e4054. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soo Jung Lee Breakdown of academic impact, for papers by Matthias Rath Breakdown of academic impact, for papers by Qiuhua Li Breakdown of academic impact, for papers by Wei‐Hwa Lee Breakdown of academic impact, for papers by Shin Kim Breakdown of academic impact, for papers by Karol Kajo Breakdown of academic impact, for papers by Weijia Zhang Breakdown of academic impact, for papers by Hui Luo Breakdown of academic impact, for papers by Alexandru Irimie
Rankless by CCL
2026